IDCareLive Sponsors

Siemens Healthcare Diagnostics, a leading provider of infectious disease testing to laboratories, offers a broad suite of scalable and automatable high-performance immunoassay, molecular and microbiology tests. Through our investment in high-quality educational training, leveraging information technology to optimize workflow, and introducing innovative new testing solutions, our infectious disease testing customers maintain their competitive edge by cost-effectively addressing rapidly changing clinical and operational needs.

Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.

Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides. The Cubist clinical product pipeline currently consists of a Phase 2 program focused on the development of a novel cephalosporin to address certain serious infections caused by multi-drug resistant (MDR) Gram-negative organisms; and a Phase 2 program for the treatment of CDAD (Clostridium difficile-associated diarrhea).